Intercept Pharmaceuticals, Inc. - Product Pipeline Review - 2014

Published: Jun, 2014 | Pages: 33 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)

Intercept Pharmaceuticals, Inc. - Product Pipeline Review - 2014

Summary

Global Markets Direct's, 'Intercept Pharmaceuticals, Inc. - Product Pipeline Review - 2014', provides an overview of the Intercept Pharmaceuticals, Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Intercept Pharmaceuticals, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Intercept Pharmaceuticals, Inc. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Intercept Pharmaceuticals, Inc.'s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the Intercept Pharmaceuticals, Inc.'s pipeline products

Reasons to buy

- Evaluate Intercept Pharmaceuticals, Inc.'s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Intercept Pharmaceuticals, Inc. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Intercept Pharmaceuticals, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Intercept Pharmaceuticals, Inc. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Intercept Pharmaceuticals, Inc.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Intercept Pharmaceuticals, Inc. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues

 Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Intercept Pharmaceuticals, Inc. Snapshot 4
Intercept Pharmaceuticals, Inc. Overview 4
Key Information 4
Key Facts 4
Intercept Pharmaceuticals, Inc. - Research and Development Overview 5
Key Therapeutic Areas 5
Intercept Pharmaceuticals, Inc. - Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products - Monotherapy 9
Intercept Pharmaceuticals, Inc. - Pipeline Products Glance 10
Intercept Pharmaceuticals, Inc. - Late Stage Pipeline Products 10
Phase III Products/Combination Treatment Modalities 10
Intercept Pharmaceuticals, Inc. - Clinical Stage Pipeline Products 11
Phase II Products/Combination Treatment Modalities 11
Phase I Products/Combination Treatment Modalities 12
Intercept Pharmaceuticals, Inc. - Early Stage Pipeline Products 13
Preclinical Products/Combination Treatment Modalities 13
Intercept Pharmaceuticals, Inc. - Drug Profiles 14
obeticholic acid 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
INT-767 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
INT-777 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
Intercept Pharmaceuticals, Inc. - Pipeline Analysis 21
Intercept Pharmaceuticals, Inc. - Pipeline Products by Target 21
Intercept Pharmaceuticals, Inc. - Pipeline Products by Route of Administration 22
Intercept Pharmaceuticals, Inc. - Pipeline Products by Molecule Type 23
Intercept Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action 24
Intercept Pharmaceuticals, Inc. - Recent Pipeline Updates 25
Intercept Pharmaceuticals, Inc. - Dormant Projects 30
Intercept Pharmaceuticals, Inc. - Locations And Subsidiaries 31
Head Office 31
Other Locations & Subsidiaries 31
Appendix 32
Methodology 32
Coverage 32
Secondary Research 32
Primary Research 32
Expert Panel Validation 32
Contact Us 33
Disclaimer 33

List of Tables
Intercept Pharmaceuticals, Inc., Key Information 4
Intercept Pharmaceuticals, Inc., Key Facts 4
Intercept Pharmaceuticals, Inc. - Pipeline by Indication, 2014 7
Intercept Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2014 8
Intercept Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2014 9
Intercept Pharmaceuticals, Inc. - Phase III, 2014 10
Intercept Pharmaceuticals, Inc. - Phase II, 2014 11
Intercept Pharmaceuticals, Inc. - Phase I, 2014 12
Intercept Pharmaceuticals, Inc. - Preclinical, 2014 13
Intercept Pharmaceuticals, Inc. - Pipeline by Target, 2014 21
Intercept Pharmaceuticals, Inc. - Pipeline by Route of Administration, 2014 22
Intercept Pharmaceuticals, Inc. - Pipeline by Molecule Type, 2014 23
Intercept Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action, 2014 24
Intercept Pharmaceuticals, Inc. - Recent Pipeline Updates, 2014 25
Intercept Pharmaceuticals, Inc. - Dormant Developmental Projects,2014 30
Intercept Pharmaceuticals, Inc., Other Locations 31